BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 22414974)

  • 1. Comparative analysis of tumor markers and evaluation of their predictive value in patients with colorectal cancer.
    Liu ZP; Li LM; Liu XL; Zhang DX
    Onkologie; 2012; 35(3):108-13. PubMed ID: 22414974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer.
    Iinuma H; Okinaga K; Egami H; Mimori K; Hayashi N; Nishida K; Adachi M; Mori M; Sasako M
    Int J Oncol; 2006 Feb; 28(2):297-306. PubMed ID: 16391782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients.
    Shen C; Hu L; Xia L; Li Y
    Jpn J Clin Oncol; 2008 Nov; 38(11):770-6. PubMed ID: 18845519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
    Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
    Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time PCR (TaqMan PCR) quantification of carcinoembryonic antigen (CEA) mRNA in the peripheral blood of colorectal cancer patients.
    Miura M; Ichikawa Y; Tanaka K; Kamiyama M; Hamaguchi Y; Ishikawa T; Yamaguchi S; Togo S; Ike H; Ooki S; Shimada H
    Anticancer Res; 2003; 23(2B):1271-6. PubMed ID: 12820382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
    Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
    Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of reverse transcriptase-polymerase chain reaction measurement of carcinoembryonic antigen mRNA levels in tumor drainage blood and peripheral blood of patients with colorectal carcinoma.
    Taniguchi T; Makino M; Suzuki K; Kaibara N
    Cancer; 2000 Sep; 89(5):970-6. PubMed ID: 10964326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
    Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM
    Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel.
    Yeh CS; Wang JY; Wu CH; Chong IW; Chung FY; Wang YH; Yu YP; Lin SR
    Int J Oncol; 2006 Feb; 28(2):411-20. PubMed ID: 16391796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative estimation of CEA and CK20 expression in tumour tissue of colorectal cancer and its liver metastases with reverse transcription and real-time PCR.
    Cerna M; Holubec L; Pesta M; Kormunda S; Topolcan O; Cerny R
    Anticancer Res; 2006; 26(1B):803-8. PubMed ID: 16739357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection and clinical study of serum tumor markers in patients with colorectal cancer].
    Zhao XW; Jiang B; Han CZ; Jing JX
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):286-8. PubMed ID: 15996321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancer.
    Nakashima S; Natsugoe S; Matsumoto M; Miyazono F; Nakajo A; Uchikura K; Tokuda K; Ishigami S; Baba M; Takao S; Aikou T
    Surgery; 2003 Feb; 133(2):162-9. PubMed ID: 12605177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
    Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
    Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of detecting disseminated tumor cells in peripheral blood of gastric and colorectal cancer patients].
    Zhang XW; Fan P; Yang HY; Yang L; Chen GY
    Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):66-9. PubMed ID: 12678992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratin 20 and vascular endothelial growth factor as molecular markers in Egyptian patients with colorectal cancer.
    Auf FA; El-Eibdy GK; Mosaad YM; El-Ghannam DM; El-Masry EE
    J Oncol Pharm Pract; 2011 Sep; 17(3):160-7. PubMed ID: 20395351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum sE-selectin levels and carcinoembryonic antigen mRNA-expressing cells in peripheral blood as prognostic factors in colorectal cancer patients.
    Ferroni P; Roselli M; Spila A; D'Alessandro R; Portarena I; Mariotti S; Palmirotta R; Buonomo O; Petrella G; Guadagni F
    Cancer; 2010 Jun; 116(12):2913-21. PubMed ID: 20336782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.